{
    "nct_id": "NCT06185205",
    "official_title": "Accelerated Super-Hypofractionated Breast Brachytherapy - ASHBY Trial",
    "inclusion_criteria": "* Female\n* New diagnosis of ductal carcinoma in situ (DCIS) and/or invasive breast carcinoma per histologic evaluation\n* Age 45-79 at diagnosis\n* Previous lumpectomy with surgical margins histologically free of invasive tumor and DCIS as determined by the pathologist.\n* T stage of Tis, T1, or T2.\n* T2 tumors must be ≤3 cm in maximum diameter\n* If the tumor is human epidermal growth factor receptor 2 (HER2)-positive, the patient must receive HER2-directed therapy.\n* For patients with invasive breast cancer, an axillary staging procedure must be performed (either sentinel node biopsy alone or axillary dissection [with a minimum of 6 axillary nodes removed]) and the axillary node[s] must be pathologically negative.\n* Note: N0(i+) is not an exclusion criterion.\n* Note: Patients meeting all of the following criteria are not required to undergo the axillary staging procedure:\n\n  * ≥70 years of age\n  * estrogen receptor, Her2 = human epidermal growth factor receptor 2, PR = progesterone receptor negative (ER+PR+HER2-)\n  * G1-2\n  * Tumor ≤2 cm in size\n  * Agrees to comply with aromatase inhibitor recommendation\n* Ability to understand and the willingness to sign a written informed consent document in English\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 45 Years\nMust have maximum age of 79 Years",
    "exclusion_criteria": "* Pregnant or breastfeeding\n* Active collagen-vascular disease\n* Paget's disease of the breast\n* History of DCIS or invasive breast cancer prior to the current diagnosis\n* Prior breast or thoracic radiation therapy (RT) for any condition\n* Multicentric carcinoma (DCIS or invasive)\n* Synchronous bilateral invasive or non-invasive breast cancer\n* Surgical margins that cannot be microscopically assessed or that are positive\n* Excision cavity that cannot be clearly delineated per the treating investigator\n* Any of the dosimetric treatment criteria defined in Section 6.1 have not been met. Patients who become ineligible due to inability to meet dosimetric criteria should not receive treatment as - defined in this protocol and will come off the study. Any subsequent adjuvant radiation will be delivered at the discretion of the treating physician\n* Medical, psychological, or social condition that, in the opinion of the investigator, may increase the patient's risk or limit the patient's adherence with study requirements",
    "miscellaneous_criteria": ""
}